The Risk for Excessive Anticoagulation With Activated Clotting Time-Guided Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement

Thijmen W. Hokken; Moniek P.M. de Maat; Nicolas M. Van Mieghem

doi:10.1016/j.shj.2024.100357

The Risk for Excessive Anticoagulation With Activated Clotting Time-Guided Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement

Thijmen W. Hokken
, Moniek P.M. de Maat
, Nicolas M. Van Mieghem^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

11 Downloads (Pure)

Original language	English
Article number	100357
Journal	Structural Heart
Volume	9
Issue number	2
DOIs	https://doi.org/10.1016/j.shj.2024.100357
Publication status	Published - Feb 2025

Access to Document

10.1016/j.shj.2024.100357Licence: CC BY

The Risk for Excessive Anticoagulation With Activated Clotting Time-Guided Monitoring in Patients Undergoing Transcatheter Aortic Valve ReplacementFinal published version, 529 KBLicence: CC BY

Cite this

@article{0884a30e6d024ec49aaddc6c011a2757,

title = "The Risk for Excessive Anticoagulation With Activated Clotting Time-Guided Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement",

author = "Hokken, \{Thijmen W.\} and \{de Maat\}, \{Moniek P.M.\} and \{Van Mieghem\}, \{Nicolas M.\}",

year = "2025",

month = feb,

doi = "10.1016/j.shj.2024.100357",

language = "English",

volume = "9",

journal = "Structural Heart",

issn = "2474-8706",

publisher = "Cardiovascular Research Foundation",

number = "2",

}

TY - JOUR

T1 - The Risk for Excessive Anticoagulation With Activated Clotting Time-Guided Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement

AU - Hokken, Thijmen W.

AU - de Maat, Moniek P.M.

AU - Van Mieghem, Nicolas M.

PY - 2025/2

Y1 - 2025/2

UR - https://www.scopus.com/pages/publications/85202920130

U2 - 10.1016/j.shj.2024.100357

DO - 10.1016/j.shj.2024.100357

M3 - Article

C2 - 40124087

AN - SCOPUS:85202920130

SN - 2474-8706

VL - 9

JO - Structural Heart

JF - Structural Heart

IS - 2

M1 - 100357

ER -

The Risk for Excessive Anticoagulation With Activated Clotting Time-Guided Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement

Access to Document

Other files and links

Cite this